You know Serum Institute of India for vaccines. But they’re also a major force in antibodies — especially biosimilars. Their partnership with Roche to produce affordable trastuzumab (Herceptin) has saved thousands of breast cancer patients in India and Africa. The India antibodies market research shows that Serum’s entry into the antibody space has forced prices...
Tiếng Việt 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)